Fig. 4: Reducing PRC1 attenuates the proliferation of HCC cells in a p53/p14-dependent manner.
From: Reducing protein regulator of cytokinesis 1 as a prospective therapy for hepatocellular carcinoma
a Cell viability and the western blots for p53 and PRC1 (right-top corner) of HepG2 cells with indicated treatments. b MTT results of HepG2 cells with indicated treatments. Taxol concentration, 10 μM. Value of control cells was arbitrarily set at 1. c, d Cell viability and the western blots for p14ARF and PRC1 (right-top corner) of Hep3B (c) and HuH-7 (d) cells with indicated treatments. e MTT results of Hep3B cells with indicated treatments. Taxol concentration, 10 μM. Value of control cells was arbitrarily set at 1 (*P < 0.05,**P < 0.01, ***P < 0.001)
